United States
Germany
Japan
United Kingdom
China
HCoV-OC43 Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus OC43 |
| Modifications | Unmodified |
Products
SARS-CoV-2 RBD rabbit monoclonal antibody, clone DM26
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 RBD rabbit monoclonal antibody, clone DM27
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
HCoV-OC43 Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus OC43 |
| Modifications | Unmodified |
HCoV-NL63 Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus NL63 |
| Modifications | Unmodified |
HCoV-229E Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus 229E |
| Modifications | Unmodified |
HCoV-HKU1 Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus HKU1 |
| Modifications | Unmodified |
HCoV-HKU1 Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus HKU1 |
| Modifications | Unmodified |
HCoV-229E Spike S2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human coronavirus 229E |
| Modifications | Unmodified |
SARS-CoV-2 Spike rabbit monoclonal antibody, clone DM40
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike rabbit monoclonal antibody, clone DM41
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike rabbit monoclonal antibody, clone DM39
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike S2 rabbit monoclonal antibody, clone DM24
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike S2 rabbit monoclonal antibody, clone DM25
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV Spike Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Modifications | Unmodified |
